Evaluating the Safety and Efficacy of Autologous Adipose Tissue-derived Mesenchymal Stem Cell Transplantation on Proinflammatory Cytokines and Anti-inflammatory Cytokines on Ageing-related Low-grade Inflammation Patients.

Phase 1/2 Unknown 72 enrolled DNA International Hospital University of Science Ho Chi Minh City · collab

NaSingle-groupOpen-labelPrevention

Summary

Single-group, open-label, phase I / II clinical trial: Evaluation of the safety of autologous adipose tissue-derived mesenchymal stem cell transplantation in inflammaging (Ageing-related low-grade inflammation) patients.

Timeline

Start: 2020-04-28
Primary completion: 2025-04-13
Completion: 2025-04-13

Publications

Nguyen NT, Phan HT, Le PM, Nguyen LT, Do TT, Phan TT, Van Le T, Dang TM, Phan CL, Dang TT, Truong NH. Safety and efficacy of autologous adipose tissue-derived stem cell transplantation in aging-related low-grade inflammation patients: a single-group, open-label, phase I clinical trial. Trials. 2024 May 8;25(1):309. doi: 10.1186/s13063-024-08128-3.

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Autologous adipose-derived mesenchymal stem cells	Cell therapy	100 cells	Intravenous

Indications

No indication recorded.